These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 14119946)

  • 1. [THE MONKEY VIRUS SV 40 IN POLIOMYELITIS VACCINE TESTS].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 191():83-9. PubMed ID: 14119946
    [No Abstract]   [Full Text] [Related]  

  • 2. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 3. [METHODS AND RESULTS OF PREPARATION OF LIVE POLIOMYELITIS VACCINE, NOT CONTAINING MIXTURES OF VACUOLIZING VIRUS (OB40-SV40)].
    CHUMAKOV MP; DZAGUROV SG; LASHKEVICH VA; GRACHEV VP; MIRONOVA LL; RALF NM; ELBERT LB
    Vopr Virusol; 1963; 29():445-9. PubMed ID: 14071282
    [No Abstract]   [Full Text] [Related]  

  • 4. [STUDIES ON TESTS FOR THE NON-TOXICITY OF INACTIVATED POLIOMYELITIS VACCINES. 1. INFLUENCE OF MAGNESIUM CHLORIDE ON THE SUSCEPTIBILITY OF MONKEY KIDNEY CELL CULTURES TO FORMALIN-TREATED POLIOMYELITIS VIRUS].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Nov; 190():313-21. PubMed ID: 14105973
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum inhibition of cytopathic effect and virus release of type 3 poliovirus vaccine in primary monkey-kidney (MK) cultures.
    ORSI EV; MESSORE G; LEVINE S; ROCA-GARCIA M
    Am J Hyg; 1961 May; 73():282-93. PubMed ID: 13731294
    [No Abstract]   [Full Text] [Related]  

  • 6. [DETECTION OF ANTIBODIES TO MONKEY VIRUS (OB40) IN HUMAN SERA. SEROLOGICAL EVIDENCE OF INFECTION FROM MONKEYS AND KIDNEY CULTURES].
    CHUMAKOVA MIa; CHUMAKOV MP; ELBERT LB; AVGUSTINOVICH GI; RALF NM; VOROSHILOVA MK; TARANOVA GP; TAPUPERE VO
    Vopr Virusol; 1963; 29():457-60. PubMed ID: 14071285
    [No Abstract]   [Full Text] [Related]  

  • 7. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 8. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 9. [USE OF THE FLUORESCENT ANTIBODY TECHNIC FOR STUDY OF THE LOCALIZATION OF SIMIAN VIRUS NO. 40 IN THE CELL AND FOR ITS RAPID DETECTION IN VACCINE].
    DZAGUROV SG; CHUMAKOV MP; KARMYSHEVA VIa; KOLIASKINA GI; GRAEVSKAIA NA; KUROCHKINA NP; PANOSIAN LB
    Vopr Virusol; 1963; 29():471-4. PubMed ID: 14071287
    [No Abstract]   [Full Text] [Related]  

  • 10. [CYTOLOGICAL STUDIES ON THE INCREASE OF SV-40 VIRUS IN TISSUE CULTURES].
    SIGNER E; MUELLER J; MAASS G
    Z Hyg Infektionskr; 1963 Jul; 149():231-54. PubMed ID: 14050558
    [No Abstract]   [Full Text] [Related]  

  • 11. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
    FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
    Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
    [No Abstract]   [Full Text] [Related]  

  • 12. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with preparation an laboratory control of oral poliomyelitis vaccine in Czechoslovakia.
    SLONIM D; MARES I; DREVO M; STURMOVA H; SIMON J
    Bull World Health Organ; 1962; 26(3):331-9. PubMed ID: 13913913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences among strains of poliomyelitis viruses in plaque size on monkey kidney cells.
    DUBES GR
    Virology; 1956 Apr; 2(2):284-8. PubMed ID: 13312227
    [No Abstract]   [Full Text] [Related]  

  • 15. [WHAT DOES THE TESTING OF VIRAL VACCINES DO FOR THE HARMLESSNESS OF VACCINES IN THEIR PRACTICAL USE?].
    BONIN O; GUENTHER O
    Med Welt; 1964 Apr; 15():822-31. PubMed ID: 14194499
    [No Abstract]   [Full Text] [Related]  

  • 16. REACTION OF POLIOVIRUS AND FORMALDEHYDE IN MAGNESIUM CHLORIDE SOLUTION TO ENHANCE POTENCY OF KILLED-VIRUS VACCINE.
    OZAKI Y; MELNICK JL
    J Immunol; 1963 Mar; 90():429-37. PubMed ID: 14051877
    [No Abstract]   [Full Text] [Related]  

  • 17. Formation of poliovirus in monkey kidney tissue culture cells.
    MAYOR HD; JORDAN LE
    Virology; 1962 Mar; 16():325-33. PubMed ID: 14471757
    [No Abstract]   [Full Text] [Related]  

  • 18. DEXTRAN SULFATE PLAQUE VARIANTS OF ATTENUATED TYPE 1 POLIOVIRUS. RELATIONSHIP TO IN VITRO AND IN VIVO MARKERS.
    TAKEMOTO KK; KIRSCHSTEIN RL
    J Immunol; 1964 Feb; 92():329-33. PubMed ID: 14160455
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of inclusions in tissue cultures of monkey kidney epithelial cells infected with poliomyelitis virus.
    BEALE AJ; STEVENS PF; DAVIS N; STACKIW W; RHODES AJ
    Can J Microbiol; 1956 May; 2(3):298-303. PubMed ID: 13316623
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytopathogenic effect of Newcastle virus in monkey kidney cultures and interference with poliomyelitis viruses.
    CHANOCK RM
    Proc Soc Exp Biol Med; 1955 Jul; 89(3):379-81. PubMed ID: 13254766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.